Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2015, Article ID 737053, 11 pages
http://dx.doi.org/10.1155/2015/737053
Review Article

Systematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis Pigmentosa

1Cornea and Ocular Surface Unit, San Raffaele Hospital IRCCS, Via Olgettina, No. 60, 20132 Milan, Italy
2Department of Biology, College of Science and Technology, Temple University, 1900 N. 12th Street, Philadelphia, PA 19122, USA
3Department of Cell Biology and Neuroscience, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy
4Department of Sense Organs, Sapienza University, Viale del Policlinico 155, 00186 Rome, Italy

Received 1 April 2015; Accepted 15 July 2015

Academic Editor: Hyeong Gon Yu

Copyright © 2015 Marta Sacchetti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. T. Hartong, E. L. Berson, and T. P. Dryja, “Retinitis pigmentosa,” The Lancet, vol. 368, no. 9549, pp. 1795–1809, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Grover, G. A. Fishman, R. J. Anderson et al., “Visual acuity impairment in patients with retinitis pigmentosa at age 45 years or older,” Ophthalmology, vol. 106, no. 9, pp. 1780–1785, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. E. L. Berson, M. A. Sandberg, B. Rosner, D. G. Birch, and A. H. Hanson, “Natural course of retinitis pigmentosa over a three-year interval,” American Journal of Ophthalmology, vol. 99, no. 3, pp. 240–251, 1985. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Naash, N. S. Peachey, Z.-Y. Li et al., “Light-induced acceleration of photoreceptor degeneration in transgenic mice expressing mutant rhodopsin,” Investigative Ophthalmology and Visual Science, vol. 37, no. 5, pp. 775–782, 1996. View at Google Scholar · View at Scopus
  5. E. M. Vingolo, M. Rocco, P. L. Grenga, S. Salvatore, and P. Pelaia, “Slowing the degenerative process, long lasting effect of hyperbaric oxygen therapy in retinitis pigmentosa,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 1, pp. 93–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Vingolo, P. Pelaia, R. Forte, M. Rocco, C. Giusti, and E. Rispoli, “Does hyperbaric oxygen (HBO) delivery rescue retinal photoreceptors in retinitis pigmentosa?” Documenta Ophthalmologica, vol. 97, no. 1, pp. 33–39, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. C. Hamel, “Retinitis pigmentosa,” Orphanet Journal of Rare Diseases, vol. 1, no. 1, article 40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. E. L. Berson, B. Rosner, M. A. Sandberg et al., “A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa,” Archives of Ophthalmology, vol. 111, no. 6, pp. 761–772, 1993. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Bahrami, M. Melia, and G. Dagnelie, “Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289],” BMC Ophthalmology, vol. 6, article 23, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. E. L. Berson, B. Rosner, M. A. Sandberg et al., “Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A,” Archives of Ophthalmology, vol. 128, no. 4, pp. 403–411, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Rotenstreich, M. Belkin, S. Sadetzki et al., “Treatment with 9-cis beta-carotene-rich powder in patients with retinitis pigmentosa a randomized crossover trial,” JAMA Ophthalmology, vol. 131, no. 8, pp. 985–992, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Kumar, N. Midha, V. Gogia, S. Gupta, S. Sehra, and A. Chohan, “Efficacy of oral valproic acid in patients with retinitis pigmentosa,” Journal of Ocular Pharmacology and Therapeutics, vol. 30, no. 7, pp. 580–586, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Nakazawa, H. Ohguro, K. Takeuchi, Y. Miyagawa, T. Ito, and T. Metoki, “Effect of nilvadipine on central visual field in retinitis pigmentosa: a 30-month clinical trial,” Ophthalmologica, vol. 225, no. 2, pp. 120–126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Merin, A. Obolensky, M. D. Farber, and I. Chowers, “A pilot study of topical treatment with an alpha2-agonist in patients with retinal dystrophies,” Journal of Ocular Pharmacology and Therapeutics, vol. 24, no. 1, pp. 80–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. D. G. Birch, R. G. Weleber, J. L. Duncan, G. J. Jaffe, and W. Tao, “Randomized trial of ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for retinitis pigmentosa,” American Journal of Ophthalmology, vol. 156, no. 2, pp. 283.e1–292.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Akiyama, Y. Ikeda, N. Yoshida et al., “Therapeutic efficacy of topical unoprostone isopropyl in retinitis pigmentosa,” Acta Ophthalmologica, vol. 92, no. 3, pp. e229–e234, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. E. L. Berson, B. Rosner, M. A. Sandberg, C. Weigel-DiFranco, and W. C. Willett, “ω-3 Intake and visual acuity in patients with retinitis pigmentosa receiving vitamin A,” Archives of Ophthalmology, vol. 130, no. 6, pp. 707–711, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Yamamoto, T. Sugawara, A. Murakami et al., “Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study,” Ophthalmology and Therapy, vol. 1, no. 1, article 5, 2012. View at Publisher · View at Google Scholar
  19. T. S. Aleman, J. L. Duncan, M. L. Bieber et al., “Macular pigment and lutein supplementation in retinitis pigmentosa and usher syndrome,” Investigative Ophthalmology and Visual Science, vol. 42, no. 8, pp. 1873–1881, 2001. View at Google Scholar · View at Scopus
  20. C. O. Harding, M. B. Gillingham, S. C. van Calcar, J. A. Wolff, J. N. Verhoeve, and M. D. Mills, “Docosahexaenoic acid and retinal function in children with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency,” Journal of Inherited Metabolic Disease, vol. 22, no. 3, pp. 276–280, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. V. Khavinson, M. Razumovsky, S. Trofimova, R. Grigorian, and A. Razumovskaya, “Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa,” Neuroendocrinology Letters, vol. 23, no. 4, pp. 365–368, 2002. View at Google Scholar · View at Scopus
  22. H. Pasantes-Morales, H. Quiroz, and O. Quesada, “Treatment with taurine, diltiazem, and vitamin E retards the progressive visual field reduction in retinitis pigmentosa: a 3-year follow-up study,” Metabolic Brain Disease, vol. 17, no. 3, pp. 183–197, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Rotenstreich, D. Harats, A. Shaish, E. Pras, and M. Belkin, “Treatment of a retinal dystrophy, fundus albipunctatus, with oral 9-cis-β-carotene,” The British Journal of Ophthalmology, vol. 94, no. 5, pp. 616–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. L. Saltzman and C. Haig, “Treatment of retinitis pigmentosa with cod liver oil injection and placental implantation,” Archives of Ophthalmology, vol. 43, no. 3, pp. 419–430, 1950. View at Publisher · View at Google Scholar
  25. M. Nakazawa, Y. Suzuki, T. Ito, T. Metoki, T. Kudo, and H. Ohguro, “Long-term effects of nilvadipine against progression of the central visual field defect in retinitis pigmentosa: an extended study,” BioMed Research International, vol. 2013, Article ID 585729, 6 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. E. L. Berson, B. Rosner, M. A. Sandberg et al., “Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses,” Archives of Ophthalmology, vol. 122, no. 9, pp. 1306–1314, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. E. L. Berson, B. Rosner, M. A. Sandberg et al., “Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment,” Archives of Ophthalmology, vol. 122, no. 9, pp. 1297–1305, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Chatzinoff, E. Nelson, N. Stahl, and A. Clahane, “Eleven-CIS vitamin A in the treatment of retinitis pigmentosa. A negative study,” Archives of Ophthalmology, vol. 80, no. 4, pp. 417–419, 1968. View at Publisher · View at Google Scholar · View at Scopus
  29. D. R. Hoffman, D. K. Hughbanks-Wheaton, N. S. Pearson et al., “Four-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX Trial): a randomized clinical trial,” JAMA Ophthalmology, vol. 132, no. 7, pp. 866–873, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. D. R. Hoffman, K. G. Locke, D. H. Wheaton, G. E. Fish, R. Spencer, and D. G. Birch, “A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa,” The American Journal of Ophthalmology, vol. 137, no. 4, pp. 704–718, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. D. K. Hughbanks-Wheaton, D. G. Birch, G. E. Fish et al., “Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial,” Investigative Ophthalmology and Visual Science, vol. 55, no. 8, pp. 4958–4966, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Newsome, F. C. Dorsey, J. G. May, D. R. Bergsma, and N. G. Bazan, “Ganglioside administration in retinitis pigmentosa,” Journal of Ocular Pharmacology, vol. 3, no. 4, pp. 323–332, 1987. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Sibulesky, K. C. Hayes, A. Pronczuk, C. Weigel-DiFranco, B. Rosner, and E. L. Berson, “Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa,” The American Journal of Clinical Nutrition, vol. 69, no. 4, pp. 656–663, 1999. View at Google Scholar · View at Scopus
  34. D. H. Wheaton, D. R. Hoffman, K. G. Locke, R. B. Watkins, and D. G. Birch, “Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa,” Archives of Ophthalmology, vol. 121, no. 9, pp. 1269–1278, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. E. L. Berson, B. Rosner, M. A. Sandberg et al., “Vitamin A supplementation for retinitis pigmentosa,” Archives of Ophthalmology, vol. 111, no. 11, pp. 1456–1459, 1993. View at Publisher · View at Google Scholar · View at Scopus
  36. D. R. Hoffman, J. C. DeMar, W. C. Heird, D. G. Birch, and R. E. Anderson, “Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa,” Journal of Lipid Research, vol. 42, no. 9, pp. 1395–1401, 2001. View at Google Scholar · View at Scopus